safety and feasibility of intravenous thrombolytic therapy in iranian patients with acute ischemic stroke

نویسندگان

masoud mehrpour department of neurology, firoozgar hospital, tehran university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (tehran university of medical sciences)

mahboubeh aghaei department of neurology, firoozgar hospital, tehran university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (tehran university of medical sciences)

mohammad reza motamed department of neurology, firoozgar hospital, tehran university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (tehran university of medical sciences)

چکیده

background: thrombolytic therapy is the only approved treatment for acute cerebral ischemia. the hemorrhagic transformation is the greatest complication of this treatment, which may occur after recanalization of occluded artery. the aim of this study was to determine factors associated with clinical improvement and worsening in patients with acute ischemic stroke treated with intravenous thrombolysis.   methods: thirty seven patients who were treated with intravenous thrombolysis between august 2010 and august 2012 who had the inclusion criteria were studied. in this prospective study, all of the admitted patients in stroke unit, monitored for at least 48 hours. we registered all patients’ information in a stroke data registry and followed them for at least 6 months.   results: thirty seven patients with acute ischemic stroke who treated with recombinant tissue plasminogen activator (r-tpa) were studied. there were hemorrhagic transformations in 9 (24%) patients. seven of them (18%) revealed intracerebral hemorrhages (ich) within the control brain ct after 24 hours without any deterioration of neurologic symptoms (asymptomatic ich). although outcomes of patients with symptomatic post r- tpa hemorrhages were worse than non-hemorrhagic post r-tpa patients, there were no significant differences between asymptomatic post r-tpa hemorrhages and non-hemorrhagic post r-tpa patients, according to the national institutes of health stroke scale (nihss) at admission (p = 0.2), after 24 hours (p= 0.07) and after 7 days (p= 0.06) post treatment.   conclusion: if the r-tpa protocol is followed carefully, the risk of symptomatic hemorrhage is low (about 7%). taking r-tpa was feasible and safe in our study population thus, it can be applied for other iranian patients.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Safety and feasibility of intravenous thrombolytic therapy in Iranian patients with acute ischemic stroke

  Background: Thrombolytic therapy is the only approved treatment for acute cerebral ischemia. The hemorrhagic transformation is the greatest complication of this treatment, which may occur after recanalization of occluded artery. The aim of this study was to determine factors associated with clinical improvement and worsening in patients with acute ischemic stroke treated with intravenous th...

متن کامل

Safety and feasibility of intravenous thrombolytic therapy in Iranian patients with acute ischemic stroke

BACKGROUND Thrombolytic therapy is the only approved treatment for acute cerebral ischemia. The hemorrhagictransformation is the greatest complication of this treatment, which may occur after recanalization of occludedartery. The aim of this study was to determine factors associated with clinical improvement and worseningin patients with acute ischemic stroke treated with intravenous thrombolys...

متن کامل

Intravenous thrombolytic therapy for acute ischemic stroke.

n engl j med 364;22 nejm.org june 2, 2011 2138 This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major clinical studies, the clinical use of this therapy, and potential adverse effects are reviewed. Relevant formal guidelines, if they exist, are presented...

متن کامل

Intravenous Thrombolytic Therapy for Acute Ischemic Stroke

n engl j med 364;22 nejm.org june 2, 2011 2138 This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major clinical studies, the clinical use of this therapy, and potential adverse effects are reviewed. Relevant formal guidelines, if they exist, are presented...

متن کامل

eligibility assessment for intravenous thrombolytic therapy in acute ischemic stroke patients; evaluating barriers for implementation

conclusions: the major barriers for thrombolytic therapy for patients with ais in this setting were delays in the provision of in-hospital services, like initial patient assessment, ct scans or laboratory studies. these results were in contrast with previous reports. background: intravenous thrombolysis is an approved treatment method for patients with acute ischemic stroke (ais) and is recomme...

متن کامل

Repeated Thrombolytic Therapy in Patients with Recurrent Acute Ischemic Stroke

BACKGROUND AND PURPOSE Widespread use of thrombolytic treatments, along with improved chances of survival after an initial ischemic stroke, increases the possibility of repeated thrombolysis. There are few reports, however, regarding repeated thrombolysis in patients who have suffered acute ischemic stroke. We explored the number and outcome of patients with repeated thrombolytic therapy in the...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
medical journal of islamic republic of iran

جلد ۲۷، شماره ۳، صفحات ۱۱۳-۱۱۸

کلمات کلیدی

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023